Sponsor content
219 result(s) found, displaying 171 to 180
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MIRCERA methoxy polyethylene glycol-epoetin beta 30 mcg solution for injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MIRCERA methoxy polyethylene glycol-epoetin beta 120 mcg solution for injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MIRCERA methoxy polyethylene glycol-epoetin beta 75 mcg solution for injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MIRCERA methoxy polyethylene glycol-epoetin beta 100 mcg solution for injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MIRCERA methoxy polyethylene glycol-epoetin beta 360 mcg solution for injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MIRCERA methoxy polyethylene glycol-epoetin beta 150 mcg solution for injection syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MIRCERA methoxy polyethylene glycol-epoetin beta 250 mcg solution for injection syringe.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Pertuzumab (rch)
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ACTEMRA tocilizumab (rch) 80 mg/4 mL injection concentrated vial.